Top-News

Oncology Med News

Keine aktuellen Kursdaten verfügbar
WKN: A0YJ16
ISIN: US68231G1022
Typ: Aktie

Oncology Med News

23.06.22 - PR Newswire
CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma
CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma PR Newswire
25.05.22 - PR Newswire
Annual General Meeting in Oncopeptides AB (publ)
Annual General Meeting in Oncopeptides AB (publ) PR Newswire
25.05.22 - PR Newswire
Annual General Meeting in Oncopeptides AB (publ)
Annual General Meeting in Oncopeptides AB (publ) PR Newswire
04.05.22 - PR Newswire
Oncopeptides publishes Q1 report 2022
Oncopeptides publishes Q1 report 2022 PR Newswire
04.05.22 - PR Newswire
Oncopeptides publishes Q1 report 2022
Oncopeptides publishes Q1 report 2022 PR Newswire
27.04.22 - PR Newswire
Invitation to presentation of Q1 report
Invitation to presentation of Q1 report PR Newswire
27.04.22 - PR Newswire
Invitation to presentation of Q1 report
Invitation to presentation of Q1 report PR Newswire
21.04.22 - PR Newswire
Oncopeptides publishes the 2021 Annual Report
Oncopeptides publishes the 2021 Annual Report PR Newswire
31.03.22 - PR Newswire
Number of shares and votes in Oncopeptides
Number of shares and votes in Oncopeptides PR Newswire
17.02.22 - PR Newswire
Oncopeptides publishes year-end report 2021
Oncopeptides publishes year-end report 2021 PR Newswire
17.02.22 - PR Newswire
Oncopeptides publishes year-end report 2021
Oncopeptides publishes year-end report 2021 PR Newswire
14.02.22 - PR Newswire
Invitation to presentation of 2021 year-end results
Invitation to presentation of 2021 year-end results PR Newswire
21.01.22 - PR Newswire
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this time
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this time PR Newswire
13.01.22 - PR Newswire
Oncopeptides phase 3 OCEAN study published in the Lancet Haematology
Oncopeptides phase 3 OCEAN study published in the Lancet Haematology PR Newswire
05.01.22 - PR Newswire
Oncopeptides announces year-end cash 2021
Oncopeptides announces year-end cash 2021 PR Newswire
05.01.22 - PR Newswire
Oncopeptides announces year-end cash 2021
Oncopeptides announces year-end cash 2021 PR Newswire
10.12.21 - PR Newswire
Oncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASH
Oncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASH PR Newswire
10.12.21 - PR Newswire
Oncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASH
Oncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASH PR Newswire
24.11.21 - PR Newswire
Oncopeptides publishes Q3 2021 report
Oncopeptides publishes Q3 2021 report PR Newswire
24.11.21 - PR Newswire
Oncopeptides publishes Q3 2021 report
Oncopeptides publishes Q3 2021 report Back to the future PR Newswire

Newssuche

Videos

09:10 Uhr -3,48%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »